(Q35293827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

review article

1 reference

title

Lung transplantation. Lung preservation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Shaf Baloch Keshavjee

series ordinal

2

object named as

Shaf Keshavjee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

Chest surgery clinics of North America

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

443-462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

The registry of the international society for heart and lung transplantation: nineteenth official report-2002.

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Donor lung procurement: assessment and operative technique.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Maximizing the utilization of donor organs offered for lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Marginal donor lungs: a reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Impact of initial flush potassium concentration on the adequacy of lung preservation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Dextran 40 at 2% versus 5% in low-potassium solutions: which is best?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Beneficial effects of leukocyte-depleted blood and low-potassium dextran solutions on microvascular permeability in preserved porcine lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Effects of EP4 solution and LPD solution vs Euro-Collins solution on Na(+)/K(+)-ATPase activity in rat alveolar type II cells and human alveolar epithelial cell line A549 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Comparison of saccharides as osmotic impermeants during hypothermic lung graft preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Raffinose improves the function of rat pulmonary grafts stored for twenty-four hours in low-potassium dextran solution

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Raffinose improves 24-hour lung preservation in low potassium dextran glucose solution: a histologic and ultrastructural analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Low-potassium dextran preservation solution improves lung function after human lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Influence of preservation solution on early graft failure in clinical lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Improved lung preservation using Euro-Collins solution for flush-perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Safe pulmonary preservation for 12 hours with low-potassium-dextran solution

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Safe lung preservation for twenty-four hours with Perfadex

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Influence of pulmonary arterial pressure during flushing on lung preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Relationship between flushing pressure and nitric oxide production in preserved lungs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Effect of hypothermic pulmonary artery flushing on capillary filtration coefficient

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Endothelium-dependent relaxation in pulmonary arteries after lung preservation and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Influence of temperature of flushing solution on lung preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Influence of the perfusate temperature on lung preservation: is there an optimum?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Hypothermic storage alone in lung preservation for transplantation: a metabolic, light microscopic, and functional analysis after 18 hours of preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Efficacy of topical cooling in lung preservation: is a reappraisal due?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Influence of deflated and anaerobic conditions during cold storage on rat lungs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Lung deflation impairs alveolar epithelial fluid transport in ischemic rabbit and rat lungs.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Effects of inflation volume during lung preservation on pulmonary capillary permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Hyperinflation of canine lung allografts during storage increases reperfusion pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Optimal alveolar oxygen concentration for cold storage of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Lung preservation: a review of current practice and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Clinical experience with retrograde lung preservation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Early lung allograft function after retrograde and antegrade preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Preimplantation retrograde pneumoplegia in clinical lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Amelioration of pulmonary allograft injury by administering a second rinse solution.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Carolina rinse solution--a new strategy to increase survival time after orthotopic liver transplantation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Rapid reperfusion causes stress failure in ischemic rat lungs.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Controlled reperfusion protects lung grafts during a transient early increase in permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Effect of ventilator-induced lung injury on the development of reperfusion injury in a rat lung transplant model.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Pulmonary transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Exhaled nitric oxide during lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

L-Arginine in lung graft preservation and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

8-Br-cyclic GMP given during reperfusion improves post-transplant lung edema and free radical injury

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Effects of various timings and concentrations of inhaled nitric oxide in lung ischemia-reperfusion. The Paris-Sud University Lung Transplantation Group

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Cytoprotective effects of nitroglycerin in ischemia-reperfusion-induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

The nitric oxide synthase cofactor tetrahydrobiopterin reduces allograft ischemia-reperfusion injury after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Nitroglycerin alters alveolar type II cell ultrastructure after ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Modulation of lung reperfusion injury by nitric oxide: impact of inspired oxygen fraction.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Inhaled nitric oxide reduces human lung allograft dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

A prospective trial of inhaled nitric oxide in clinical lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

A randomized trial of inhaled nitric oxide to prevent reperfusion injury following lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Administration of prostaglandin E1 after lung transplantation improves early graft function

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Evidence that intraoperative prostaglandin E1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Primary graft failure following lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Protection against gas exchange abnormalities by pre-aerosolized PGE1, iloprost and nitroprusside in lung ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Predominant role for C5b-9 in renal ischemia/reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Surfactant replacement in reperfusion injury after clinical lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Combined exogenous surfactant and inhaled nitric oxide therapy for lung ischemia-reperfusion injury in minipigs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

Severe reperfusion lung injury after double lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-3359%2803%2900055-3

7 January 2021

10.1016/S1052-3359(03)00055-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13678307%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference